GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $701,000 | +223.0% | 10,300 | +51.2% | 0.05% | +165.0% |
Q2 2022 | $217,000 | +261.7% | 6,810 | +290.0% | 0.02% | +300.0% |
Q1 2022 | $60,000 | -6.2% | 1,746 | -20.6% | 0.01% | 0.0% |
Q4 2021 | $64,000 | +255.6% | 2,200 | +514.5% | 0.01% | -58.3% |
Q1 2020 | $18,000 | -61.7% | 358 | -60.2% | 0.01% | +140.0% |
Q2 2019 | $47,000 | -33.8% | 900 | -52.4% | 0.01% | 0.0% |
Q3 2018 | $71,000 | -15.5% | 1,890 | +1.1% | 0.01% | -16.7% |
Q2 2018 | $84,000 | +236.0% | 1,869 | +251.3% | 0.01% | +200.0% |
Q1 2018 | $25,000 | -73.4% | 532 | -77.8% | 0.00% | -77.8% |
Q4 2017 | $94,000 | +422.2% | 2,394 | +295.0% | 0.01% | +350.0% |
Q3 2017 | $18,000 | -48.6% | 606 | -53.3% | 0.00% | -33.3% |
Q2 2017 | $35,000 | -74.1% | 1,298 | -64.6% | 0.00% | -78.6% |
Q1 2017 | $135,000 | +145.5% | 3,664 | -5.3% | 0.01% | +133.3% |
Q4 2016 | $55,000 | +71.9% | 3,870 | +173.7% | 0.01% | +50.0% |
Q3 2016 | $32,000 | – | 1,414 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |